These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

940 related items for PubMed ID: 19768385

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Ex vivo generated regulatory T cells modulate experimental autoimmune myasthenia gravis.
    Aricha R, Feferman T, Fuchs S, Souroujon MC.
    J Immunol; 2008 Feb 15; 180(4):2132-9. PubMed ID: 18250419
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The Th1/Th2/Th17/Treg paradigm induced by stachydrine hydrochloride reduces uterine bleeding in RU486-induced abortion mice.
    Li X, Wang B, Li Y, Wang L, Zhao X, Zhou X, Guo Y, Jiang G, Yao C.
    J Ethnopharmacol; 2013 Jan 09; 145(1):241-53. PubMed ID: 23178269
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Prophylactic administration of fingolimod (FTY720) ameliorated experimental autoimmune myasthenia gravis by reducing the number of dendritic cells, follicular T helper cells and antibody-secreting cells.
    Liu Y, Yang CL, Yang B, Du T, Li XL, Zhang P, Ge MR, Lian Y, Li H, Liu YD, Duan RS.
    Int Immunopharmacol; 2021 Jul 09; 96():107511. PubMed ID: 33915521
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The expression levels of transcription factors T-bet, GATA-3, RORγt and FOXP3 in peripheral blood lymphocyte (PBL) of patients with liver cancer and their significance.
    Lin ZW, Wu LX, Xie Y, Ou X, Tian PK, Liu XP, Min J, Wang J, Chen RF, Chen YJ, Liu C, Ye H, Ou QJ.
    Int J Med Sci; 2015 Jul 09; 12(1):7-16. PubMed ID: 25552913
    [Abstract] [Full Text] [Related]

  • 33. Suppression of experimental myasthenia gravis by a B-cell epitope-free recombinant acetylcholine receptor.
    Yi HJ, Chae CS, So JS, Tzartos SJ, Souroujon MC, Fuchs S, Im SH.
    Mol Immunol; 2008 Nov 09; 46(1):192-201. PubMed ID: 18799218
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals.
    Shi FD, Bai XF, Li HL, Huang YM, Van der Meide PH, Link H.
    Clin Exp Immunol; 1998 Mar 09; 111(3):506-12. PubMed ID: 9528890
    [Abstract] [Full Text] [Related]

  • 36. Interleukin 10 aggravates experimental autoimmune myasthenia gravis through inducing Th2 and B cell responses to AChR.
    Zhang GX, Xiao BG, Yu LY, van der Meide PH, Link H.
    J Neuroimmunol; 2001 Feb 01; 113(1):10-8. PubMed ID: 11137572
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
    Feili-Hariri M, Falkner DH, Morel PA.
    J Leukoc Biol; 2005 Sep 01; 78(3):656-64. PubMed ID: 15961574
    [Abstract] [Full Text] [Related]

  • 39. Experimental autoimmune myasthenia gravis may occur in the context of a polarized Th1- or Th2-type immune response in rats.
    Saoudi A, Bernard I, Hoedemaekers A, Cautain B, Martinez K, Druet P, De Baets M, Guéry JC.
    J Immunol; 1999 Jun 15; 162(12):7189-97. PubMed ID: 10358165
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 47.